Show simple item record

dc.contributor.authorVoulgaris, E.en
dc.contributor.authorPentheroudakis, Georgeen
dc.contributor.authorPavlidis, Nicholasen
dc.creatorVoulgaris, E.en
dc.creatorPentheroudakis, Georgeen
dc.creatorPavlidis, Nicholasen
dc.date.accessioned2018-06-22T09:53:26Z
dc.date.available2018-06-22T09:53:26Z
dc.date.issued2011
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/41837
dc.description.abstractBackground: Pregnancy complicated by cancer is relatively rare but, as women in western societies tend to delay childbearing to the third and fourth decade of life, this phenomenon is going to be encountered more often in the future. Material and methods: Review of the literature and description of the different diagnostic and therapeutic approaches which are required to diagnose and treat pregnant mothers with cancer. Results: As in non-pregnant patients, every effort should be made to provide the maximal benefit and best prognosis to the pregnant patient. In most cases, in order to avoid any harm to the fetus, different diagnostic approach should be incorporated and treatment should be tailored to each pregnant woman. Cooperation of multidisciplinary teams, incorporating medical and radiation oncologists, surgeons, obstetricians, neonatologists and experienced nursing staff, is required to provide optimal care for the patient. The benefits from use of surgery, chemotherapy and/or radiotherapy as well as the mother's wishes and beliefs need to be factored into recommendations and treatment planning. Conclusions: With the experience gained, the developments in clinical and radiation oncology and the cooperation of multidisciplinary teams, treatment of cancer during pregnancy with normal fetal outcome is feasible. © 2011 Elsevier Ltd. All rights reserved.en
dc.language.isoengen
dc.sourceSurgical oncologyen
dc.subjectFemaleen
dc.subjectAntineoplastic agentsen
dc.subjectCancer chemotherapyen
dc.subjectCisplatinen
dc.subjectCyclophosphamideen
dc.subjectDacarbazineen
dc.subjectDoxorubicinen
dc.subjectFluorouracilen
dc.subjectHumanen
dc.subjectMethotrexateen
dc.subjectNeoplasmsen
dc.subjectTamoxifenen
dc.subjectVinblastineen
dc.subjectHumansen
dc.subjectBreast canceren
dc.subjectCarboplatinen
dc.subjectPaclitaxelen
dc.subjectPriority journalen
dc.subjectPrognosisen
dc.subjectAntiemetic agenten
dc.subjectNavelbineen
dc.subjectOxaliplatinen
dc.subjectTaxane derivativeen
dc.subjectReviewen
dc.subjectCancer surgeryen
dc.subjectNeoplasticen
dc.subjectPregnancyen
dc.subjectPregnancy complicationsen
dc.subjectPregnant womanen
dc.subjectTreatment planningen
dc.subjectCancer diagnosisen
dc.subjectCancer radiotherapyen
dc.subjectCleft palateen
dc.subjectImatiniben
dc.subjectBisphosphonic acid derivativeen
dc.subjectCarmustineen
dc.subjectEpirubicinen
dc.subjectIrinotecanen
dc.subjectMelanomaen
dc.subjectNeoplasmen
dc.subjectTrastuzumaben
dc.subjectUterine cervix canceren
dc.subjectRecombinant erythropoietinen
dc.subjectReview literature as topicen
dc.subjectCanceren
dc.subjectNonhumanen
dc.subjectDiagnosisen
dc.subjectTreatmenten
dc.subjectSorafeniben
dc.subjectSunitiniben
dc.subjectHormonal therapyen
dc.subjectMedical specialisten
dc.subjectRituximaben
dc.subjectAnthracyclineen
dc.subjectParacetamolen
dc.subjectSurgeonen
dc.subjectLeukemiaen
dc.subjectFetotoxicityen
dc.subjectFetus malformationen
dc.subjectPregnancy outcomeen
dc.subjectPregnancy terminationen
dc.subjectRadiation exposureen
dc.subjectRhabdomyosarcomaen
dc.subjectCraniofacial malformationen
dc.subjectDasatiniben
dc.subjectFetus risken
dc.subjectNilotiniben
dc.subjectObstetricsen
dc.subjectTracheoesophageal fistulaen
dc.subjectVentriculomegalyen
dc.titleCancer and pregnancy: A comprehensive reviewen
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.suronc.2011.06.002
dc.description.volume20
dc.description.issue4
dc.description.startingpagee175
dc.description.endingpagee185
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidPavlidis, Nicholas [0000-0002-2195-9961]
dc.contributor.orcidPentheroudakis, George [0000-0002-6632-2462]
dc.gnosis.orcid0000-0002-2195-9961
dc.gnosis.orcid0000-0002-6632-2462


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record